Press Releases
Our team at Pharmafocuseurope.com believes that press releases are an important marketing tool for highlighting a client's corporate message and ensuring it reaches their target audience. The feature can be used to publish business agreements, annual reports, financial results, corporate performances, important announcements, and any other important information that needs to be communicated to the target audience. Pharma companies can also use it to launch new products and promote existing ones.
Ventus Therapeutics Announces First Participant Dosed in Clinical Study with an NLRP3 Inhibitor Licensed Exclusively to Novo Nordisk
Saturday, May 04, 2024Ventus Therapeutics Inc a clinicalstage biopharmaceutical company utilizing its proprietary structural biology and computational chemistry platform ReSOLVE
BridgeBio launches BridgeBio Oncology Therapeutics (BBOT) with $200M of private external capital to accelerate the development of its novel precision oncology pipeline
Friday, May 03, 2024BridgeBio Pharma Inc a commercialstage biopharmaceutical company focused on genetic diseases and cancers has announced the completion of a M private
Alkermes plc Completes Sale of Athlone, Ireland Facility to Novo Nordisk
Friday, May 03, 2024Alkermes plc has completed the previously announced sale of its development and manufacturing facility in Athlone Ireland to Novo Nordisk In connection with the closing of the transaction Alkermes will receive a onetime cash payment
Astellas and Poseida Therapeutics Enter Into Research Collaboration and License Agreement to Develop Novel Allogeneic Cell Therapies in Oncology
Thursday, May 02, 2024Astellas Pharma Inc and Poseida Therapeutics Inc today announced that Xyphos Biosciences Inc and Poseida have entered into a research collaboration
Repare Therapeutics & Debiopharm Announce First Patient Dosed in Phase 1/1b MYTHIC Trial Evaluating the Synthetic Lethal Combination of PKMYT1 and WEE1 Inhibition
Thursday, May 02, 2024Repare Therapeutics Inc a leading clinicalstage precision oncology company and Debiopharm a privatelyowned Swissbased biopharmaceutical company
G1 Therapeutics and Pepper Bio Announce Global (Excluding Asia-Pac) License Agreement for Lerociclib
Wednesday, May 01, 2024G Therapeutics Inc a commercialstage oncology company and Pepper Bio the worlds first transomics drug discovery and development company announced a global licensing agreement
Deciphera Pharmaceuticals to be Acquired by ONO Pharmaceutical For $2.4 Billion
Tuesday, April 30, 2024Deciphera Pharmaceuticals Inc a biopharmaceutical company focused on discovering developing and commercializing important new medicines to improve the lives of people with cancer today announced that it has entered
Collegium Announces Authorized Generic Agreement with Hikma Pharmaceuticals USA Inc. for Nucynta® and Nucynta® ER
Tuesday, April 30, 2024Collegium Pharmaceutical Inc a leading diversified specialty pharmaceutical company committed to improving the lives of people living with serious medical
Sino Biological Finalizes the Acquisition of SignalChem Biotech, Strengthening Global Presence and Expanding Product Portfolio
Monday, April 29, 2024Sino Biological Inc a biotechnology company listed on the Shenzhen stock exchange subsidiary ChiNext specializing in biological research reagents
Jeraygo (Aprocitentan) Recommended for Approval in Europe for the Treatment of Resistant Hypertension
Monday, April 29, 2024Idorsia Ltd announced today that the Committee for Medicinal Products for Human Use the scientific committee of the European Medicines Agency adopted a positive opinion for the use of JERAYGO
